The impact of SARS-CoV-2 vaccination in Dravet syndrome: A UK survey

CONCLUSION: Overall, these results suggest that SARS-CoV-2 vaccines are safe and well tolerated in individuals with DS, as they are in most people without DS. In most people with DS, SARS-CoV-2 vaccine does not appear to be associated with an increase in the frequency or duration of seizures, even in those who develop fever post-vaccination. Many caregivers are concerned about a person with DS receiving a SARS-CoV-2 vaccine, with some reporting that they would decline a SARS-CoV-2 vaccine when offered. It is crucial that healthcare professionals are proactive in providing accurate information regarding the risks and benefits of vaccination in this population, given the potential for serious outcomes from infection.PMID:34536735 | PMC:PMC8379095 | DOI:10.1016/j.yebeh.2021.108258
Source: Epilepsy and Behaviour - Category: Neurology Authors: Source Type: research